Published in Antimicrob Agents Chemother on July 01, 1989
Management of infectious diarrhoea. Gut (2004) 1.36
Antimicrobial resistance of Shigella isolates causing traveler's diarrhea. Antimicrob Agents Chemother (1994) 1.36
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results. J Accid Emerg Med (1994) 0.85
Role of quinolones in the treatment of diarrhoeal diseases. Drugs (1995) 0.78
Quinolones in the treatment of acute bacterial diarrhoeal diseases. Drugs (1993) 0.77
Statement on travellers' diarrhea. Committee to Advise on Tropical Medicine and Travel. CMAJ (1995) 0.75
The new quinolones in the treatment of diarrhoea and typhoid fever. Drugs (1995) 0.75
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother (1983) 2.70
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother (1984) 2.43
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother (1983) 2.20
Antibiotics in acute bacillary dysentery; observations in 1,408 cases with positive cultures. J Am Med Assoc (1953) 1.75
Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrob Agents Chemother (1984) 1.63
Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med (1987) 1.61
Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J Pediatr (1967) 1.57
Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA (1976) 1.56
Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis (1986) 1.49
Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med (1987) 1.17
Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones. Antimicrob Agents Chemother (1988) 1.09
Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim. Br Med J (Clin Res Ed) (1984) 1.04
Single-dose tetracycline therapy for shigellosis in adults. JAMA (1978) 1.02
Bacillary dysentery due to multidrug resistant Sh. dysenteriae type 1. Indian J Med Res (1980) 0.91
The treatment of shigellosis with antibiotics. Ann N Y Acad Sci (1952) 0.90
Drug resistant shigellosis in south India. Indian J Med Res (1978) 0.89
Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. Br Med J (Clin Res Ed) (1987) 0.87
The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection (1987) 0.85
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens. Drugs Exp Clin Res (1985) 0.85
Antimicrobial therapy for infectious diarrhea. Rev Infect Dis (1986) 0.82
Rise and fall of shigella antibiotic resistance. Antimicrob Agents Chemother (1980) 0.80
Quinolones in the treatment of gastrointestinal infections. Chemioterapia (1987) 0.79
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01
The development of human benign prostatic hyperplasia with age. J Urol (1984) 8.29
Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48
Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res (2001) 5.40
Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02
Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis (2001) 3.78
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69
Cytotoxic enterotoxin produced by Aeromonas hydrophila: relationship of toxigenic isolates to diarrheal disease. Infect Immun (1979) 3.65
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene (2011) 3.59
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24
Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol (1999) 3.11
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med (1993) 3.07
Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol (1969) 3.01
Antitoxin responses to infections with enterotoxigenic Escherichia coli. J Infect Dis (1974) 2.88
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene (2008) 2.72
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69
Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol (1987) 2.58
Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56
Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun (1992) 2.41
Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl Environ Microbiol (2001) 2.41
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis (2001) 2.20
Enterotoxigenic Escherichia coli: identification and characterization. J Infect Dis (1980) 2.16
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico. J Clin Microbiol (1987) 2.10
Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol (1994) 2.07
The aquatic flora and fauna as reservoirs of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1994) 2.04
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect Immun (1997) 2.01
Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01
Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg (1999) 1.95
Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res (1992) 1.92
Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis (1992) 1.91
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin Diagn Lab Immunol (1995) 1.89
Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. J Clin Microbiol (1979) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Experimental cholera. A canine model. Lancet (1966) 1.88
Acute toxicity of vitamin A given with vaccines in infancy. Lancet (1993) 1.87
Immunization with Escherichia coli enterotoxin protects against homologous enterotoxin challenge. Infect Immun (1973) 1.86
Prevalence of enterotoxin genes in Aeromonas spp. isolated from children with diarrhea, healthy controls, and the environment. J Clin Microbiol (2000) 1.85
Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology (1979) 1.84
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Molecular analysis of rRNA and cholera toxin genes carried by the new epidemic strain of toxigenic Vibrio cholerae O139 synonym Bengal. J Clin Microbiol (1994) 1.79
Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis (1993) 1.77
The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V. cholerae O1 or non-O1 progenitors. J Infect Dis (2000) 1.76
Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75
Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69
New insights on the emergence of cholera in Latin America during 1991: the Peruvian experience. Am J Trop Med Hyg (2000) 1.66
The spatial epidemiology of cholera in an endemic area of Bangladesh. Soc Sci Med (2002) 1.65
Acute respiratory infections in children: a community-based longitudinal study in rural Bangladesh. J Trop Pediatr (1997) 1.64
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62
Helicobacter pylori populations in Peruvian patients. Clin Infect Dis (1997) 1.57
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
Antigenic similarity of heat-labile enterotoxins from diverse strains of Escherichia coli. J Clin Microbiol (1977) 1.55
Identifying environmental risk factors for endemic cholera: a raster GIS approach. Health Place (2002) 1.49
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth. Oncogene (2009) 1.48
Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect Immun (1991) 1.47
Development and evaluation of rapid monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol (1994) 1.47
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatr (2001) 1.47
Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun (1999) 1.46
Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes. J Clin Microbiol (1992) 1.44
The current status of oral therapy in the treatment of acute diarrheal illness. Am J Clin Nutr (1978) 1.43
Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol (2010) 1.43
Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41
Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun (1983) 1.41
Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect Immun (1993) 1.40
Comparison of home glucose monitoring with the oral glucose tolerance test to detect gestational glucose intolerance. J Fam Pract (1994) 1.39
Molecular subtyping of toxigenic Vibrio cholerae O139 causing epidemic cholera in India and Bangladesh, 1992-1993. J Infect Dis (1995) 1.37
Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J Clin Microbiol (1993) 1.36
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children. J Pediatr (1986) 1.36
Differentiation of Shigella flexneri strains by rRNA gene restriction patterns. J Clin Microbiol (1992) 1.35
Comparison of sucrose and glucose in the oral electrolyte therapy of cholera and other severe diarrheas. N Engl J Med (1977) 1.35
Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. J Infect Dis (1994) 1.35
The influence of epididymal agenesis on the development and maturation of the testis: experimental model and clinical correlations. Urol Res (1984) 1.34